Litigation Details for Ferring Pharmaceuticals Inc. v. Fresenius Kabi USA, LLC (D. Del. 2020)
✉ Email this page to a colleague
Ferring Pharmaceuticals Inc. v. Fresenius Kabi USA, LLC (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-03-26 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 9,415,085; 9,579,359 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Ferring Pharmaceuticals Inc. v. Fresenius Kabi USA, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Ferring Pharmaceuticals Inc. v. Fresenius Kabi USA, LLC (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-12-11 | 223 | Opinion - Memorandum Opinion | (“the ’870 patent”), 9,415,085 (“the ’085 patent”), 10,695,398 (“the ’398 patent”), 8,828,938 (“the …The CV Patents The ’085 patent and the ’398 patent (collectively, the “CV patents”) are…” (’359 patent cl. 1; ’739 patent cl. 1, 14, 27; ’085 patent cl. 1; ’398 patent cl. 1, …’359 patent cl. 2; ’739 patent cl. 2, 15, 28; ’085 patent cl. 3, 5, 9; ’398 patent cl. …United States Patent Nos. 9,579,359 (“the ’359 patent”), 10,729,739 (“the ’739 patent”), 10,973,870 ( | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
